Literature DB >> 17557041

Nonerosive reflux disease.

J D Long1, R C Orlando.   

Abstract

Nonerosive reflux disease (NERD) is the most common phenotype of gastroesophageal reflux disease. By definition, patients with NERD have typical reflux symptoms caused by the intraesophageal reflux of gastric contents but have no visible esophageal mucosal injury. This is in contrast to patients with erosive reflux disease (ERD) or Barrett's esophagus (BE) who have obvious esophageal mucosal injury on endosco-py. Only 50% of patients with NERD have pathologic esophageal acid exposure as detected on 24-h pH monitoring. NERD patients with physiologic esophageal acid exposure and good temporal correlation of symptoms with reflux events are considered to have esophageal hypersensitivity, while patients with no symptom-reflux correlation are considered to have functional heartburn. It is possible yet uncommon for NERD to progress to severe ERD (i.e. LA Grade C or D) or BE. Patients with NERD and pathologic esophageal acid exposure have motor dysfunction and acid reflux abnormalities that are similar to patients with ERD and BE, whereas NERD patients with physiologic esophageal acid exposure have minimal abnormalities and are not much different than healthy controls. The pathological feature most indicative of NERD is the presence of dilated intercellular spaces within squamous epithelium, an ultrastructural abnormality readily identified on transmission electron microscopy but also on light microscopy. A symptomatic response to an empiric trial of high-dose proton pump inhibitor (PPI) therapy is a simple and useful strategy to establish the diagnosis of NERD, although histology and pH monitoring may be useful in confirming the diagnosis. Patients with NERD suffer similar decrements in quality of life as do patients with erosive esophagitis. Therapy is aimed at eliminating or reducing symptoms and improving quality of life. PPIs are the most effective agents for the treatment of NERD although they are less effective in providing symptom relief than in patients with erosive esophagitis. Laparoscopic antireflux surgery is an effective therapy for selected patients with NERD and outcomes are better when performed in high volume centers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17557041

Source DB:  PubMed          Journal:  Minerva Gastroenterol Dietol        ISSN: 1121-421X


  11 in total

1.  Impact of gastro-esophageal reflux on mucin mRNA expression in the esophageal mucosa.

Authors:  Aafke H C van Roon; George C Mayne; Bas P L Wijnhoven; David I Watson; Mary P Leong; Gabriëlle E Neijman; Michael Z Michael; Andrew R McKay; David Astill; Damian J Hussey
Journal:  J Gastrointest Surg       Date:  2008-05-02       Impact factor: 3.452

2.  Technical problems produced by the Bravo pH test in nonerosive reflux disease patients.

Authors:  Andrés de Hoyos; Edgar Alain Esparza
Journal:  World J Gastroenterol       Date:  2010-07-07       Impact factor: 5.742

3.  Non-erosive and uncomplicated erosive reflux diseases: Difference in physiopathological and symptom pattern.

Authors:  Vittorio Bresadola; Gian Luigi Adani; Francesco Londero; Cosimo Alex Leo; Vittorio Cherchi; Dario Lorenzin; Anna Rossetto; Gianmatteo Vit; Umberto Baccarani; Giovanni Terrosu; Dino De Anna
Journal:  World J Gastrointest Pathophysiol       Date:  2011-06-15

4.  Non-erosive reflux disease manifested exclusively by protracted hiccups.

Authors:  Andrés de Hoyos; Edgar A Esparza; María Cervantes-Sodi
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

5.  Risk factors for proton pump inhibitor refractoriness in Chinese patients with non-erosive reflux disease.

Authors:  Xiao-Ping Niu; Bao-Ping Yu; Yun-Dong Wang; Zhen Han; Shao-Fen Liu; Chi-Yi He; Guo-Zheng Zhang; Wan-Chun Wu
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

6.  Manometric findings in patients with isolated distal gastroesophageal reflux.

Authors:  Yasemin Ozin; Ulku Dagli; Sedef Kuran; Burhan Sahin
Journal:  World J Gastroenterol       Date:  2009-11-21       Impact factor: 5.742

7.  Alterations in the non-neuronal acetylcholine synthesis and release machinery in esophageal epithelium.

Authors:  Amanda S Wolf-Johnston; Ann T Hanna-Mitchell; Charles A Buffington; Sunita Shinde; James R Roppolo; Emeran Mayer; Lori A Birder
Journal:  Life Sci       Date:  2012-04-30       Impact factor: 5.037

8.  Cytoprotective effects of hydrogen sulfide in novel rat models of non-erosive esophagitis.

Authors:  Oksana Zayachkivska; Olena Havryluk; Nazar Hrycevych; Nazar Bula; Oksana Grushka; John L Wallace
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

9.  Application of electron microscopy in gastroenterology.

Authors:  Masaya Iwamuro; Haruo Urata; Takehiro Tanaka; Hiroyuki Okada
Journal:  World J Gastrointest Pathophysiol       Date:  2022-01-15

Review 10.  Pharmacological and Safety Profile of Dexlansoprazole: A New Proton Pump Inhibitor - Implications for Treatment of Gastroesophageal Reflux Disease in the Asia Pacific Region.

Authors:  Khean Lee Goh; Myung Gyu Choi; Ping I Hsu; Hoon Jai Chun; Varocha Mahachai; Udom Kachintorn; Somchai Leelakusolvong; Nayoung Kim; Abdul Aziz Rani; Benjamin C Y Wong; Justin Wu; Cheng Tang Chiu; Vikram Shetty; Joseph C Bocobo; Melchor M Chan; Jaw-Town Lin
Journal:  J Neurogastroenterol Motil       Date:  2016-07-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.